Mary Glenn Fowler

Summary

Publications

  1. pmc Growth, immune and viral responses in HIV infected African children receiving highly active antiretroviral therapy: a prospective cohort study
    Philippa M Musoke
    Department of Paediatrics and Child Health, Makerere University, Kampala, Uganda
    BMC Pediatr 10:56. 2010
  2. pmc Further evidence that exclusive breast-feeding reduces mother-to-child HIV transmission compared with mixed feeding
    Mary Glenn Fowler
    Makerere University Makere University Johns Hopkins University Research Collaboration, Kampala, Uganda
    PLoS Med 5:e63. 2008
  3. doi request reprint Perinatal HIV and its prevention: progress toward an HIV-free generation
    Mary Glenn Fowler
    Department of Pathology, The Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD 21224, USA
    Clin Perinatol 37:699-719, vii. 2010
  4. ncbi request reprint Reducing the risk of mother-to-child human immunodeficiency virus transmission: past successes, current progress and challenges, and future directions
    Mary Glenn Fowler
    Department of Pathology, Johns Hopkins Medical School, onsite Makerere University Johns Hopkins University Research Collaboration, Kampala, Uganda
    Am J Obstet Gynecol 197:S3-9. 2007
  5. pmc In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine
    Jessica D Church
    Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
    AIDS Res Hum Retroviruses 25:673-7. 2009
  6. pmc Predictors of early and late mother-to-child transmission of HIV in a breastfeeding population: HIV Network for Prevention Trials 012 experience, Kampala, Uganda
    Francis A Mmiro
    Makerere University Johns Hopkins University Research Collaboration, Kampala, Uganda
    J Acquir Immune Defic Syndr 52:32-9. 2009
  7. doi request reprint Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy
    Taha E Taha
    Dept of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD 21205, USA
    J Infect Dis 200:1490-7. 2009
  8. doi request reprint Long-term follow-up of children in the HIVNET 012 perinatal HIV prevention trial: five-year growth and survival
    Maxensia Owor
    Clinical Division, Makerere University Johns Hopkins University Research Collaboration, Kampala, Uganda Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA Department of Pediatrics and Child Health, Makerere University, Kampala, Uganda Science Facilitation Department, Family Health International, Durham, NC Department of Pathology, Johns Hopkins University, Baltimore, MD and Department of Epidemiology and Biostatistics, George Washington University School of Public Health and Health Services, Washington, DC
    J Acquir Immune Defic Syndr 64:464-71. 2013
  9. doi request reprint Postexposure prophylaxis of breastfeeding HIV-exposed infants with antiretroviral drugs to age 14 weeks: updated efficacy results of the PEPI-Malawi trial
    Taha E Taha
    Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21205, USA
    J Acquir Immune Defic Syndr 57:319-25. 2011
  10. pmc Effects of cessation of breastfeeding in HIV-1-exposed, uninfected children in Malawi
    Taha E Taha
    Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland 21205, USA
    Clin Infect Dis 53:388-95. 2011

Detail Information

Publications62

  1. pmc Growth, immune and viral responses in HIV infected African children receiving highly active antiretroviral therapy: a prospective cohort study
    Philippa M Musoke
    Department of Paediatrics and Child Health, Makerere University, Kampala, Uganda
    BMC Pediatr 10:56. 2010
    ..We documented the weight and height responses in HIV infected Ugandan children on highly active antiretroviral therapy and determined clinical factors associated with successful treatment outcomes...
  2. pmc Further evidence that exclusive breast-feeding reduces mother-to-child HIV transmission compared with mixed feeding
    Mary Glenn Fowler
    Makerere University Makere University Johns Hopkins University Research Collaboration, Kampala, Uganda
    PLoS Med 5:e63. 2008
  3. doi request reprint Perinatal HIV and its prevention: progress toward an HIV-free generation
    Mary Glenn Fowler
    Department of Pathology, The Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD 21224, USA
    Clin Perinatol 37:699-719, vii. 2010
    ....
  4. ncbi request reprint Reducing the risk of mother-to-child human immunodeficiency virus transmission: past successes, current progress and challenges, and future directions
    Mary Glenn Fowler
    Department of Pathology, Johns Hopkins Medical School, onsite Makerere University Johns Hopkins University Research Collaboration, Kampala, Uganda
    Am J Obstet Gynecol 197:S3-9. 2007
    ..The challenges to eliminate new perinatal HIV infections worldwide will depend on both sustaining and expanding PMTCT interventions and effective primary HIV prevention for women, adolescents, and young adults...
  5. pmc In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine
    Jessica D Church
    Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
    AIDS Res Hum Retroviruses 25:673-7. 2009
    ..NVP resistance was still detected in some infants 6-12 months after sdNVP exposure. In this study, in utero HIV infection was the only factor associated with detection of NVP resistance in infants 6-8 weeks after sdNVP exposure...
  6. pmc Predictors of early and late mother-to-child transmission of HIV in a breastfeeding population: HIV Network for Prevention Trials 012 experience, Kampala, Uganda
    Francis A Mmiro
    Makerere University Johns Hopkins University Research Collaboration, Kampala, Uganda
    J Acquir Immune Defic Syndr 52:32-9. 2009
    ..To determine the predictors for early versus later (breastfeeding) transmission of HIV-1...
  7. doi request reprint Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy
    Taha E Taha
    Dept of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD 21205, USA
    J Infect Dis 200:1490-7. 2009
    ..The association between postnatal human immunodeficiency virus type 1 (HIV-1) transmission and maternal highly active antiretroviral therapy (HAART) after infant extended antiretroviral prophylaxis was assessed...
  8. doi request reprint Long-term follow-up of children in the HIVNET 012 perinatal HIV prevention trial: five-year growth and survival
    Maxensia Owor
    Clinical Division, Makerere University Johns Hopkins University Research Collaboration, Kampala, Uganda Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA Department of Pediatrics and Child Health, Makerere University, Kampala, Uganda Science Facilitation Department, Family Health International, Durham, NC Department of Pathology, Johns Hopkins University, Baltimore, MD and Department of Epidemiology and Biostatistics, George Washington University School of Public Health and Health Services, Washington, DC
    J Acquir Immune Defic Syndr 64:464-71. 2013
    ..To describe 5-year growth, survival, and long-term safety among children exposed to nevirapine or zidovudine in an African perinatal prevention trial, HIVNET 012...
  9. doi request reprint Postexposure prophylaxis of breastfeeding HIV-exposed infants with antiretroviral drugs to age 14 weeks: updated efficacy results of the PEPI-Malawi trial
    Taha E Taha
    Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21205, USA
    J Acquir Immune Defic Syndr 57:319-25. 2011
    ..This analysis updates and extends efficacy estimates of the PEPI-Malawi trial through age 24 months at study completion in September 2009...
  10. pmc Effects of cessation of breastfeeding in HIV-1-exposed, uninfected children in Malawi
    Taha E Taha
    Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland 21205, USA
    Clin Infect Dis 53:388-95. 2011
    ..We assessed morbidity rates during short intervals that accompanied weaning and cumulative mortality among HIV-exposed, uninfected infants enrolled in the postexposure prophylaxis of infants in Malawi (PEPI-Malawi) trial...
  11. doi request reprint Kinetics of nevirapine and its impact on HIV-1 RNA levels in maternal plasma and breast milk over time after perinatal single-dose nevirapine
    Jim Aizire
    Makerere University Johns Hopkins University Research Collaboration, Kampala, Uganda
    J Acquir Immune Defic Syndr 60:483-8. 2012
    ..To determine kinetics after single-dose nevirapine and the impact on HIV RNA [viral load (VL)] in maternal plasma and breast milk (BM)...
  12. ncbi request reprint Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmission
    J Brooks Jackson
    Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    AIDS 20:217-22. 2006
    ..To correlate nevirapine presence and concentration in cord bloods of infants born to HIV-1 infected women with report of timing of dose and HIV-1 transmission at 6 weeks of age...
  13. pmc Initiation of antiretroviral treatment in women after delivery can induce multiclass drug resistance in breastfeeding HIV-infected infants
    Jessica Fogel
    Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
    Clin Infect Dis 52:1069-76. 2011
    ..Infants in the trial received single-dose NVP and a week of zidovudine (ZDV) at birth; some infants also received extended daily NVP prophylaxis, with or without extended ZDV prophylaxis...
  14. pmc Analysis of nevirapine resistance mutations in cloned HIV type 1 variants from HIV-infected Ugandan infants using a single-step amplification-sequencing method (AmpliSeq)
    William Ian Towler
    Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
    AIDS Res Hum Retroviruses 24:1209-13. 2008
    ..This analysis revealed numerous NVP resistance mutations not detected by population sequencing, genetically linked NVP resistance mutations, and a high degree of genetic complexity at codons that influence NVP susceptibility...
  15. pmc Analysis of HIV tropism in Ugandan infants
    Jessica D Church
    Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Curr HIV Res 8:498-503. 2010
    ..3%) infants with R5-tropic HIV (p=0.09). Higher R5-RLU at 6-8 weeks was not associated with decreased survival. Infants with in utero infection had a higher median R5-RLU than infants who were HIV-uninfected at birth (p=0.025)...
  16. pmc Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-month results of a randomized, double-blind, placebo-controlled trial
    Mary Glenn Fowler
    Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD Maternal Adolescent and Child Health, University of the Witwatersrand, South Africa Fred Hutchinson Cancer Research Center, Seattle, WA Department of Pediatrics, Stanford University School of Medicine, Stanford, CA Department of Obstetrics and Gynecology, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe Centre for the AIDS Programme of Research in South Africa CAPRISA, Nelson R Mandela School of Medicine, University of KwaZulu Natal, Durban, South Africa Makerere University, Johns Hopkins University, Research Collaboration, Kampala, Uganda Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania Department of Pediatrics, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe Department of Global Health and Population, Harvard University School of Public Health, Boston, MA Family Health International, Research Triangle Park, NC Division of HIV AIDS, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, MD and Maternal and Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Rockville, MD
    J Acquir Immune Defic Syndr 65:366-74. 2014
    ..HPTN 046 compared the efficacy and safety of infant nevirapine (NVP) among HIV-exposed breastfed infants randomized at 6 weeks to 6 months to t NVP or placebo to prevent postnatal infection: we report final 18-month outcomes...
  17. doi request reprint Immunogenicity of ALVAC-HIV vCP1521 in infants of HIV-1-infected women in Uganda (HPTN 027): the first pediatric HIV vaccine trial in Africa
    Pontiano Kaleebu
    Medical Research Council Uganda Virus Research Institute, Entebbe, Uganda SCHARP, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA Viral and Rickettsial Disease Laboratory, Richmond, CA Joint Clinical Research Center, Kampala, Uganda Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD Makerere University Johns Hopkins University Research Collaboration, Kampala, Uganda Department of Paediatrics and Child Health, College of Health Sciences, Makerere University, Kampala, Uganda George Washington University School of Public Health and Health Services, Washington, DC FHI 360, Durham, NC and Sanofi Pasteur, Discovery Drive, Swiftwater, PA
    J Acquir Immune Defic Syndr 65:268-77. 2014
    ..Testing protective HIV-1 vaccines remains a critical priority. The immunogenicity of ALVAC-HIV vCP1521 (ALVAC) in infants born to HIV-1-infected women in Uganda was evaluated in the first pediatric HIV-1 vaccine study in Africa...
  18. pmc Stavudine concentrations in women receiving postpartum antiretroviral treatment and their breastfeeding infants
    Jessica M Fogel
    Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    J Acquir Immune Defic Syndr 60:462-5. 2012
    ..Although d4T is concentrated in breast milk relative to maternal plasma, the infant d4T dose received from breast milk is very small and not clinically significant...
  19. ncbi request reprint Response to antiretroviral therapy in HIV-infected Ugandan children exposed and not exposed to single-dose nevirapine at birth
    Philippa M Musoke
    Makerere University Johns Hopkins University Research Collaboration, Kampala, Uganda
    J Acquir Immune Defic Syndr 52:560-8. 2009
    ..To compare the response to a nevirapine (NVP)-based highly active antiretroviral therapy (HAART) in HIV-infected Ugandan children, exposed and nonexposed to single-dose NVP (sd NVP) at birth...
  20. ncbi request reprint Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial
    J Brooks Jackson
    Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    Lancet 362:859-68. 2003
    ..Safety and efficacy data are now presented for all babies followed up to 18 months of age...
  21. pmc Emergence and persistence of nevirapine resistance in breast milk after single-dose nevirapine administration
    Sarah E Hudelson
    Department of Pathology, Johns Hopkins University School of Medicine, 720 Rutland Avenue, Baltimore, MD 21205, USA
    AIDS 24:557-61. 2010
    ..Single-dose nevirapine (NVP) (sdNVP) can reduce the risk of HIV vertical transmission. We assessed risk factors for NVP resistance in plasma and breast milk from sdNVP-exposed Ugandan women...
  22. pmc Extended prophylaxis with nevirapine and cotrimoxazole among HIV-exposed uninfected infants is well tolerated
    Jim Aizire
    Makerere University, Johns Hopkins University Research Collaboration, Kampala, Uganda
    AIDS 26:325-33. 2012
    ..Nevirapine and cotrimoxazole are associated with hematologic toxicities and skin-rash. Safety of their concurrent use for prophylaxis over extended periods among HIV-exposed uninfected infants has not been previously assessed...
  23. doi request reprint Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission
    Newton I Kumwenda
    Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA
    N Engl J Med 359:119-29. 2008
    ..Effective strategies are urgently needed to reduce mother-to-child transmission of human immunodeficiency virus type 1 (HIV-1) through breast-feeding in resource-limited settings...
  24. pmc Nevirapine resistance in women and infants after first versus repeated use of single-dose nevirapine for prevention of HIV-1 vertical transmission
    Tamara S Flys
    Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
    J Infect Dis 198:465-9. 2008
    ..NVP resistance was detected in a similar proportion of infants born to SD NVP-naive versus SD NVP-experienced women. Repeated use of SD NVP to prevent HIV transmission does not appear to influence NVP resistance...
  25. pmc Safety and efficacy of HIV hyperimmune globulin for prevention of mother-to-child HIV transmission in HIV-1-infected pregnant women and their infants in Kampala, Uganda (HIVIGLOB/NVP STUDY)
    Carolyne Onyango-Makumbi
    Makerere University, Johns Hopkins University Research Collaboration MU JHU CARE LTD, Kampala, Uganda
    J Acquir Immune Defic Syndr 58:399-407. 2011
    ..Primary objectives were to determine rates of HIV infection among infants and to assess the safety of HIVIGLOB in combination with sdNVP in HIV-infected Ugandan pregnant women and their infants...
  26. pmc Distribution of haematological and chemical pathology values among infants in Malawi and Uganda
    Newton I Kumwenda
    Johns Hopkins Bloomberg School of Public Health, Baltimore, USA
    Paediatr Int Child Health 32:213-27. 2012
    ..Data on paediatric reference laboratory values are limited for sub-Saharan Africa...
  27. ncbi request reprint Long-term clinical and immunologic outcomes of HIV-infected women with and without previous exposure to nevirapine
    Peter K Mudiope
    Makerere University Johns Hopkins University Research Collaboration, Kampala, Uganda
    Trop Med Int Health 18:344-51. 2013
    ....
  28. pmc Considerations in using US-based laboratory toxicity tables to evaluate laboratory toxicities among healthy malawian and Ugandan infants
    Irene R Lubega
    Makerere University Johns Hopkins University Research Collaboration, Kampala, Uganda
    J Acquir Immune Defic Syndr 55:58-64. 2010
    ....
  29. pmc Total lymphocyte count: not a surrogate marker for risk of death in HIV-infected Ugandan children
    Philippa M Musoke
    Department of Paediatrics and Child Health, Makerere University, Kampala, Uganda
    J Acquir Immune Defic Syndr 49:171-8. 2008
    ..To determine the utility of total lymphocyte count (TLC) in predicting the 12-month mortality in HIV-infected Ugandan children and to correlate TLC and CD4 cell %...
  30. ncbi request reprint Performance characteristics of HIV-1 culture and HIV-1 DNA and RNA amplification assays for early diagnosis of perinatal HIV-1 infection
    John S Lambert
    Institute of Human Virology, University of Maryland, Baltimore, USA
    J Acquir Immune Defic Syndr 34:512-9. 2003
    ..Given that RNA assays require less blood volume and yield rapid results, our study adds to existing data suggesting that RNA assays may be used for early diagnosis of HIV-1 infection in infants...
  31. pmc Antibody maturation and viral diversification in HIV-infected women
    Maria M James
    Department of Pathology, Johns Hopkins Univ School of Medicine, Baltimore, Maryland, United States of America
    PLoS ONE 8:e57350. 2013
    ..Antibody maturation and viral diversification were examined in these women...
  32. doi request reprint The impact of maternal highly active antiretroviral therapy and short-course combination antiretrovirals for prevention of mother-to-child transmission on early infant infection rates at the Mulago national referral hospital in Kampala, Uganda, January 20
    Zikulah Namukwaya
    Makerere University Johns Hopkins Research Collaboration, Mulago Hospital, Uganda
    J Acquir Immune Defic Syndr 56:69-75. 2011
    ..We describe the antiretroviral (ARV) drugs given in the Mulago Hospital prevention of mother-to-child transmission (PMTCT) program from January 2007 to May 2009 and its impact on early infant HIV infection rates...
  33. pmc Feasibility and safety of ALVAC-HIV vCP1521 vaccine in HIV-exposed infants in Uganda: results from the first HIV vaccine trial in infants in Africa
    Kenneth Kintu
    Makerere University Johns Hopkins University Research Collaboration, Kampala, Uganda
    J Acquir Immune Defic Syndr 63:1-8. 2013
    ..Safety and feasibility results from phase 1, randomized, double-blind, placebo-controlled trial of ALVAC-HIV vCP1521 in infants born to HIV type 1-infected women in Uganda are reported...
  34. ncbi request reprint Phase I/II trial of HIV-1 hyperimmune globulin for the prevention of HIV-1 vertical transmission in Uganda
    Laura A Guay
    Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    AIDS 16:1391-400. 2002
    ..To assess the safety, tolerance, pharmacokinetics, and virologic and immunologic changes associated with the use of Ugandan HIV hyperimmune globulin (HIVIGLOB) in HIV infected pregnant Ugandan women and their infants...
  35. ncbi request reprint Does prior short-course nevirapine reduce the effectiveness of subsequent combination treatment with efavirenz?
    Mary Glenn Fowler
    J Acquir Immune Defic Syndr 34:348-50. 2003
  36. ncbi request reprint Effect of cessation of zidovudine prophylaxis to reduce vertical transmission on maternal HIV disease progression and survival
    Arlene D Bardeguez
    University of Medicine and Dentistry of New Jersey, Newark, New Jersey 07103, USA
    J Acquir Immune Defic Syndr 32:170-81. 2003
    ....
  37. ncbi request reprint A review of clinical trials to prevent mother-to-child HIV-1 transmission in Africa and inform rational intervention strategies
    Monica L Nolan
    AIDS 16:1991-9. 2002
  38. ncbi request reprint Breast-feeding and HIV-1 transmission in resource-limited settings
    Mary Glenn Fowler
    Maternal Child Transmission, Pediatric and Adolescent Studies Section, Epidemiology Branch, Division of HIV AIDS Prevention, Centers for Disease Control, Atlanta, Georgia 30333, USA
    J Acquir Immune Defic Syndr 30:230-9. 2002
    ..These research efforts using maternal antiretrovirals for perinatal HIV prevention during breast-feeding will interface with emerging plans for treatment programs in developing countries...
  39. doi request reprint Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials
    Abubaker Bedri
    Lancet 372:300-13. 2008
    ..The aim of three trials in Ethiopia, India, and Uganda was to assess whether daily nevirapine given to breastfed infants through 6 weeks of age can decrease HIV transmission via breastfeeding...
  40. ncbi request reprint Prevention of HIV transmission through breast-feeding: strengthening the research agenda
    Francois Dabis
    Centre for Paediatric Epidemiology and Biostatistics, Institute of Child Health, University College, London, UK
    J Acquir Immune Defic Syndr 35:167-8. 2004
    ..These papers summarize the current state of knowledge and highlight the outstanding issues that will need to be addressed in the very near future before research advances can be translated into public health practice...
  41. ncbi request reprint Recommendations for human immunodeficiency virus screening, prophylaxis, and treatment for pregnant women in the United States
    Denise J Jamieson
    Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, GA 30341, USA
    Am J Obstet Gynecol 197:S26-32. 2007
    ..For women with HIV RNA levels of < 1000 copies/mL, a 3-part zidovudine prophylaxis regimen (prenatal, intrapartum, and neonatal) should be used alone or in combination with other antiretroviral drugs...
  42. ncbi request reprint Balancing maternal and infant benefits and the consequences of breast-feeding in the developing world during the era of HIV infection
    Catherine M Wilfert
    J Infect Dis 195:165-7. 2007
  43. ncbi request reprint Prevention of human immunodeficiency virus-1 transmission to the infant through breastfeeding: new developments
    Athena P Kourtis
    Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Am J Obstet Gynecol 197:S113-22. 2007
    ..Passive (antibodies) and active (vaccine) immunoprophylaxis will also soon begin to be tested. This paper focuses on current and planned research on strategies to prevent breastfeeding transmission of HIV...
  44. ncbi request reprint Toward elimination of perinatal human immunodeficiency virus transmission in the United States: effectiveness of funded prevention programs, 1999-2001
    Stephanie L Sansom
    Division of HIV AIDS Prevention, National Center for HIV, STD, and TB Prevention, Information Technology Support, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Am J Obstet Gynecol 197:S90-5. 2007
    ..24). The number of perinatal HIV infections in the funded areas decreased by 56%, achieving the Centers for Disease Control and Prevention's goal of a 50% reduction in incidence by 2005...
  45. ncbi request reprint Effectiveness of repeat single-dose nevirapine for prevention of mother-to-child transmission of HIV-1 in repeat pregnancies in Uganda
    Michelle McConnell
    Global AIDS Program, Centers for Disease Control and Prevention, Atlanta, GA, USA
    J Acquir Immune Defic Syndr 46:291-6. 2007
    ..Given detection of resistant mutants among women who receive SDNVP, concerns have arisen over the efficacy of SDNVP in repeat pregnancies...
  46. ncbi request reprint The interface of perinatal HIV prevention, antiretroviral drug resistance, and antiretroviral treatment: what do we really know?
    Mary Glenn Fowler
    J Acquir Immune Defic Syndr 34:308-11. 2003
  47. ncbi request reprint Cost-effectiveness of HIV rescreening during late pregnancy to prevent mother-to-child HIV transmission in South Africa and other resource-limited settings
    Sada Soorapanth
    Centers for Disease Control and Prevention, Atlanta, GA, USA
    J Acquir Immune Defic Syndr 42:213-21. 2006
    ..Overall, HIV rescreening late in pregnancy in high-prevalence, resource-limited settings such as South Africa would be a cost-effective strategy for reducing mother-to-child transmission...
  48. ncbi request reprint Antiretroviral prophylaxis of perinatal HIV-1 transmission and the potential impact of antiretroviral resistance
    Monica Nolan
    Epidemiology Branch, Division of HIV AIDS, NCHSTP, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Acquir Immune Defic Syndr 30:216-29. 2002
    ....
  49. ncbi request reprint Updated estimates of healthcare utilization and costs among perinatally HIV-infected children
    Stephanie L Sansom
    Epidemiology Branch, Division of HIV AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Acquir Immune Defic Syndr 41:521-6. 2006
    ..This study examined changes in healthcare use among perinatally HIV-infected children and developed new estimates of expected lifetime treatment costs...
  50. ncbi request reprint Prevention of mother-to-child transmission of HIV-1 through breast-feeding: past, present, and future
    Marc Bulterys
    J Infect Dis 189:2149-53. 2004
  51. ncbi request reprint Roundtable. Revisiting the role of single-dose nevirapine for preventing perinatal HIV transmission
    Hoosen Coovadia
    AIDS Clin Care 17:61-4. 2005
  52. ncbi request reprint Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004
    Joann Schulte
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Pediatrics 119:e900-6. 2007
    ..Our goal was to determine trends in low birth weight and preterm birth among US infants born to HIV-infected women...
  53. pmc Role of traditional birth attendants in preventing perinatal transmission of HIV
    Marc Bulterys
    Epidemiology Branch, Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    BMJ 324:222-4. 2002
  54. ncbi request reprint Combination antiretroviral therapy in african nursing mothers and drug exposure in their infants: new pharmacokinetic and virologic findings
    Marc Bulterys
    J Infect Dis 192:709-12. 2005
  55. ncbi request reprint Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to zidovudine during gestation or postnatally and treated with didanosine or zidovudine in the first three months of life
    Andrea Kovacs
    Maternal, Child and Adolescent Center for Infectious Diseases and Virology, University of Southern California, Keck School of Medicine, Los Angeles, 90033, USA
    Pediatr Infect Dis J 24:503-9. 2005
    ..There are limited numbers of drugs that are available in formulations that are appropriate for neonates and few studies assessing resistance among infants born to human immunodeficiency virus (HIV)-infected women...
  56. ncbi request reprint Pediatricians' role and practices regarding provision of guidance about sexual risk reduction to parents
    Kim S Miller
    Division of HIV AIDS Prevention SE, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS E 45, Atlanta, GA, 30333, USA
    J Prim Prev 29:279-91. 2008
    ....
  57. ncbi request reprint Infant human immunodeficiency virus diagnosis in resource-limited settings: issues, technologies, and country experiences
    Tracy L Creek
    Centers for Disease Control and Prevention National Center for HIV, Hepatitis, STD, TB Prevention Global AIDS Program, Atlanta, GA 30333, USA
    Am J Obstet Gynecol 197:S64-71. 2007
    ..This paper reviews challenges and progress in the field and suggests ways to facilitate early infant testing in resource-limited settings...
  58. ncbi request reprint Rapid human immunodeficiency virus-1 testing on labor and delivery in 17 US hospitals: the MIRIAD experience
    Denise J Jamieson
    Division of HIV AIDS Prevention, National Center for HIV AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Am J Obstet Gynecol 197:S72-82. 2007
    ..Routine rapid testing during labor provides a feasible, acceptable, and accurate way to identify HIV-infected women before delivery...
  59. ncbi request reprint Trends in antiretroviral therapy use and survival rates for a large cohort of HIV-infected children and adolescents in the United States, 1989-2001
    Michelle S McConnell
    Division of Applied Public Health Training, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Acquir Immune Defic Syndr 38:488-94. 2005
    ..In the United States, HIV-infected children and adolescents are aging and using antiretroviral (ARV) therapy for extended periods of time...
  60. ncbi request reprint Increasing trend of Cesarean deliveries in HIV-infected women in the United States from 1994 to 2000
    Kenneth L Dominguez
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road, M S E 45, Atlanta, GA 30333, USA
    J Acquir Immune Defic Syndr 33:232-8. 2003
    ..Meta-analysis and randomized clinical trial results reported in June 1998 indicated a significant reduction in perinatal HIV transmission rates among mothers undergoing a cesarean section (C-section)...
  61. ncbi request reprint Human immunodeficiency virus retesting during pregnancy: costs and effectiveness in preventing perinatal transmission
    Stephanie L Sansom
    National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Obstet Gynecol 102:782-90. 2003
    ..To estimate the incremental societal costs and effectiveness of a second human immunodeficiency virus (HIV) antibody test during the third trimester of pregnancy compared with no second test...
  62. ncbi request reprint Use of enhanced perinatal human immunodeficiency virus surveillance methods to assess antiretroviral use and perinatal human immunodeficiency virus transmission in the United States, 1999-2001
    Norma S Harris
    Centers for Disease Control and Prevention, National Center for HIV, STD, and TB Prevention, Division of HIV AIDS Prevention, Atlanta, GA, USA
    Am J Obstet Gynecol 197:S33-41. 2007
    ..Significant reductions in perinatal human immunodeficiency virus (HIV) transmission have been demonstrated in which the HIV-infected mothers and their HIV-exposed infants receive prenatal, intrapartum, and neonatal antiretroviral therapy...